Evidence map›Paper›PMID 28035580›Full record

ArticleMedical oncology (Northwood, London, England)2017

Simultaneous PET/MRI assessment of response to cytotoxic and hormone neo-adjuvant chemotherapy in breast cancer: a preliminary report.

Valeria Romeo, Massimiliano D'Aiuto, Giuseppe Frasci, Massimo Imbriaco, Emanuele Nicolai

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Breast PET/MRI Hybrid Imaging and Targeted Tracers.Journal of magnetic resonance imaging : JMRI · 2023
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Valeria RomeoDepartment of Advanced Biomedical Sciences, University Federico II of Naples, Via S. Pansini, 5, 80123, Naples, Italy. valeria.romeo@unina.it.ORCID http://orcid.org/0000-0002-1603-6396
Massimiliano D'AiutoBreast Department, National Cancer Institute of Naples IRCCS "G. Pascale", Naples, Italy.
Giuseppe FrasciBreast Department, National Cancer Institute of Naples IRCCS "G. Pascale", Naples, Italy.
Massimo ImbriacoDepartment of Advanced Biomedical Sciences, University Federico II of Naples, Via S. Pansini, 5, 80123, Naples, Italy.
Emanuele NicolaiIRCCS SDN, Naples, Italy.
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITFederico II University Hospital · ITSDN Istituto di Ricerca Diagnostica e Nucleare · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to assess the response to cytotoxic and hormone neo-adjuvant chemotherapy in four patients with locally advanced breast cancer by simultaneous PET/MRI. Four patients with locally advanced breast cancer underwent simultaneous PET/MRI of the breast using a 3 T Biograph mMR before and after neo-adjuvant chemotherapy (two patients were treated with hormone-therapy and two patients were treated with cytotoxic chemotherapy). Morpho-structural tumoral features and tumor size were assessed; area value, metabolic (SUV and MTV) and functional (ADC, K

Indexed as

AdultAgedAntineoplastic AgentsAntineoplastic Agents, HormonalBreast NeoplasmsChemotherapy, AdjuvantFemaleHumansMagnetic Resonance ImagingMiddle AgedMultimodal ImagingNeoadjuvant TherapyPositron-Emission TomographyAntineoplastic AgentsAntineoplastic Agents, HormonalBreast cancerNeo-adjuvant chemotherapySimultaneous PET/MRI

Identifiers

PMID28035580
OpenAlexW2563736982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.